{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T09:08:16Z","timestamp":1791623296020,"version":"4.3.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["No.ZR2023MH376"],"award-info":[{"award-number":["No.ZR2023MH376"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["No. ZR2023QH193"],"award-info":[{"award-number":["No. ZR2023QH193"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["No.82400231"],"award-info":[{"award-number":["No.82400231"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["No.82270200, No.82070203\uff0cNo.81770210"],"award-info":[{"award-number":["No.82270200, No.82070203\uff0cNo.81770210"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["No. 2023M741506"],"award-info":[{"award-number":["No. 2023M741506"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Taishan Scholars Program of Shandong Province"},{"name":"Shandong Provincial Engineering Research Center of Lymphoma"},{"DOI":"10.13039\/100014103","name":"Key Research and Development Program of Shandong Province","doi-asserted-by":"crossref","award":["No.2018CXGC1213"],"award-info":[{"award-number":["No.2018CXGC1213"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Academic Promotion Programme of Shandong First Medical University","award":["No. 2019QL018"],"award-info":[{"award-number":["No. 2019QL018"]}]},{"name":"Translational Research Grant of NCRCH","award":["No.2021WWB02, No.2020ZKMB01"],"award-info":[{"award-number":["No.2021WWB02, No.2020ZKMB01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10495-025-02112-1","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T20:27:26Z","timestamp":1744403246000},"page":"1482-1501","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Metabolism-related ALDH1B1 acts as potential predictor and therapeutic target for primary gastrointestinal diffuse large B-cell lymphoma"],"prefix":"10.1007","volume":"30","author":[{"given":"Qiqi","family":"Qiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjuan","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosheng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunfeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"2112_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1182\/blood-2014-05-577189","volume":"125","author":"LH Sehn","year":"2015","unstructured":"Sehn LH, Gascoyne RD (2015) Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity. Blood 125:22\u201332. https:\/\/doi.org\/10.1182\/blood-2014-05-577189","journal-title":"Blood"},{"key":"2112_CR2","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1155\/2012\/480160","volume":"26","author":"JM Howell","year":"2012","unstructured":"Howell JM, Auer-Grzesiak I, Zhang J, Andrews CN, Stewart D, Urbanski SJ (2012) Increasing incidence rates, distribution and histological characteristics of primary Gastrointestinal non-Hodgkin lymphoma in a North American population. Can J Gastroenterol 26:452\u2013456. https:\/\/doi.org\/10.1155\/2012\/480160","journal-title":"Can J Gastroenterol"},{"key":"2112_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/1751-2980.12234","volume":"16","author":"JC Peng","year":"2015","unstructured":"Peng JC, Zhong L, Ran ZH (2015) Primary lymphomas in the Gastrointestinal tract. J Dig Dis 16:169\u2013176. https:\/\/doi.org\/10.1111\/1751-2980.12234","journal-title":"J Dig Dis"},{"key":"2112_CR4","doi-asserted-by":"publisher","first-page":"232470961989354","DOI":"10.1177\/2324709619893546","volume":"7","author":"P Ramachandran","year":"2019","unstructured":"Ramachandran P, Sahni S, Wang JC (2019) De Novo CD5\u2009+\u2009Primary Gastrointestinal diffuse large B-Cell lymphoma: challenges with treatment and clinical course. J Investig Med High Impact Case Rep 7:2324709619893546. https:\/\/doi.org\/10.1177\/2324709619893546","journal-title":"J Investig Med High Impact Case Rep"},{"key":"2112_CR5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s11605-015-3052-4","volume":"20","author":"AL Lightner","year":"2016","unstructured":"Lightner AL, Shannon E, Gibbons MM, Russell MM (2016) Primary Gastrointestinal Non-Hodgkin\u2019s lymphoma of the small and large intestines: a systematic review. J Gastrointest Surg 20:827\u2013839. https:\/\/doi.org\/10.1007\/s11605-015-3052-4","journal-title":"J Gastrointest Surg"},{"key":"2112_CR6","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2147\/CMAR.S295671","volume":"13","author":"Y Shen","year":"2021","unstructured":"Shen Y, Ou J, Wang B, Wang L, Xu J, Cen X (2021) Influence of severe Gastrointestinal complications in primary Gastrointestinal diffuse large B-Cell lymphoma. Cancer Manag Res 13:1041\u20131052. https:\/\/doi.org\/10.2147\/CMAR.S295671","journal-title":"Cancer Manag Res"},{"key":"2112_CR7","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1182\/blood-2013-09-524108","volume":"123","author":"Z Zhou","year":"2014","unstructured":"Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, Vanderplas A, Zelenetz AD, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson M, Niland J, Gascoyne RD, Connors JM, Friedberg JW, Winter JN (2014) An enhanced international prognostic index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood 123:837\u2013842. https:\/\/doi.org\/10.1182\/blood-2013-09-524108","journal-title":"Blood"},{"key":"2112_CR8","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1023\/a:1008351427601","volume":"10","author":"S Cortelazzo","year":"1999","unstructured":"Cortelazzo S, Rossi A, Roggero F, Oldani E, Zucca E, Tondini C, Ambrosetti A, Pasini F, Pinotti G, Bertini M, Vitolo U, Busetto M, Gianni L, Cavalli F, Barbui T (1999) Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma. International extranodal lymphoma study group (IELSG). Ann Oncol 10:1433\u20131440. https:\/\/doi.org\/10.1023\/a:1008351427601","journal-title":"Ann Oncol"},{"key":"2112_CR9","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.3748\/wjg.v27.i35.5932","volume":"27","author":"MD Diamantidis","year":"2021","unstructured":"Diamantidis MD, Papaioannou M, Hatjiharissi E (2021) Primary gastric non-Hodgkin lymphomas: recent advances regarding disease pathogenesis and treatment. World J Gastroenterol 27:5932\u20135945. https:\/\/doi.org\/10.3748\/wjg.v27.i35.5932","journal-title":"World J Gastroenterol"},{"key":"2112_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1055\/s-2006-942344","volume":"19","author":"FJ Quayle","year":"2006","unstructured":"Quayle FJ, Lowney JK (2006) Colorectal lymphoma. Clin Colon Rectal Surg 19:49\u201353. https:\/\/doi.org\/10.1055\/s-2006-942344","journal-title":"Clin Colon Rectal Surg"},{"key":"2112_CR11","doi-asserted-by":"publisher","first-page":"e0238807","DOI":"10.1371\/journal.pone.0238807","volume":"15","author":"HJ Kang","year":"2020","unstructured":"Kang HJ, Lee HH, Jung SE, Park KS, O JH, Jeon YW, Choi BO, Cho SG (2020) Pattern of failure and optimal treatment strategy for primary gastric diffuse large B-cell lymphoma treated with R-CHOP chemotherapy. PLoS ONE 15:e0238807. https:\/\/doi.org\/10.1371\/journal.pone.0238807","journal-title":"PLoS ONE"},{"key":"2112_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/nrgastro.2012.255","volume":"10","author":"H Vanheel","year":"2013","unstructured":"Vanheel H, Farre R (2013) Changes in Gastrointestinal tract function and structure in functional dyspepsia. Nat Rev Gastroenterol Hepatol 10:142\u2013149. https:\/\/doi.org\/10.1038\/nrgastro.2012.255","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2112_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/ijc.33530","volume":"149","author":"G Nagel","year":"2021","unstructured":"Nagel G, Bjorge T, Jaensch A, Peter RS, Haggstrom C, Lang A, Engeland A, Teleka S, Jirstrom K, Lindquist D, Stattin P, Ulmer H, Concin H, Stocks T (2021) Metabolic factors and the risk of small intestine cancers: pooled study of 800 000 individuals in the metabolic syndrome and cancer project. Int J Cancer 149:66\u201374. https:\/\/doi.org\/10.1002\/ijc.33530","journal-title":"Int J Cancer"},{"key":"2112_CR14","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/ijc.33725","volume":"149","author":"N Papadimitriou","year":"2021","unstructured":"Papadimitriou N, Gunter MJ, Murphy N, Gicquiau A, Achaintre D, Brezina S, Gumpenberger T, Baierl A, Ose J, Geijsen A, van Roekel EH, Gsur A, Gigic B, Habermann N, Ulrich CM, Kampman E, Weijenberg MP, Ueland PM, Kaaks R, Katzke V, Krogh V, Bueno-de-Mesquita B, Ardanaz E, Travis RC, Schulze MB, Sanchez MJ, Colorado-Yohar SM, Weiderpass E, Scalbert A, Keski-Rahkonen P (2021) Circulating Tryptophan metabolites and risk of colon cancer: results from case-control and prospective cohort studies. Int J Cancer 149:1659\u20131669. https:\/\/doi.org\/10.1002\/ijc.33725","journal-title":"Int J Cancer"},{"key":"2112_CR15","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/ijc.33877","volume":"150","author":"S Wang","year":"2022","unstructured":"Wang S, Li M, Yan L, He M, Lin H, Xu Y, Wan Q, Qin G, Chen G, Xu M, Wang G, Qin Y, Luo Z, Tang X, Wang T, Zhao Z, Xu Y, Chen Y, Huo Y, Hu R, Ye Z, Dai M, Shi L, Gao Z, Su Q, Mu Y, Zhao J, Chen L, Zeng T, Yu X, Li Q, Shen F, Chen L, Zhang Y, Wang Y, Deng H, Liu C, Wu S, Yang T, Li D, Ning G, Wu T, Wang W, Bi Y, Lu J, Group CS (2022) Metabolomics study reveals systematic metabolic dysregulation and early detection markers associated with incident pancreatic cancer. Int J Cancer 150:1091\u20131100. https:\/\/doi.org\/10.1002\/ijc.33877","journal-title":"Int J Cancer"},{"key":"2112_CR16","doi-asserted-by":"publisher","first-page":"e70171","DOI":"10.1002\/ctm2.70171","volume":"15","author":"Y Jia","year":"2025","unstructured":"Jia Y, Wan M, Shen Y, Wang J, Luo X, He M, Bai R, Xiao W, Zhang X, Ruan J (2025) Predictive nomogram integrating radiomics and multi-omics for improved prognosis-model in cholangiocarcinoma. Clin Transl Med 15:e70171. https:\/\/doi.org\/10.1002\/ctm2.70171","journal-title":"Clin Transl Med"},{"key":"2112_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.drup.2016.09.003","volume":"29","author":"P Icard","year":"2016","unstructured":"Icard P, Lincet H (2016) The reduced concentration of citrate in cancer cells: an indicator of cancer aggressiveness and a possible therapeutic target. Drug Resist Updat 29:47\u201353. https:\/\/doi.org\/10.1016\/j.drup.2016.09.003","journal-title":"Drug Resist Updat"},{"key":"2112_CR18","doi-asserted-by":"publisher","first-page":"100671","DOI":"10.1016\/j.drup.2019.100671","volume":"49","author":"X Cao","year":"2020","unstructured":"Cao X, Hou J, An Q, Assaraf YG, Wang X (2020) Towards the overcoming of anticancer drug resistance mediated by p53 mutations. Drug Resist Updat 49:100671. https:\/\/doi.org\/10.1016\/j.drup.2019.100671","journal-title":"Drug Resist Updat"},{"key":"2112_CR19","doi-asserted-by":"publisher","first-page":"100712","DOI":"10.1016\/j.drup.2020.100712","volume":"52","author":"N Shahar","year":"2020","unstructured":"Shahar N, Larisch S (2020) Inhibiting the inhibitors: targeting anti-apoptotic proteins in cancer and therapy resistance. Drug Resist Updat 52:100712. https:\/\/doi.org\/10.1016\/j.drup.2020.100712","journal-title":"Drug Resist Updat"},{"key":"2112_CR20","doi-asserted-by":"publisher","first-page":"7291","DOI":"10.1158\/0008-5472.CAN-11-1715","volume":"71","author":"TG Sommermann","year":"2011","unstructured":"Sommermann TG, O\u2019Neill K, Plas DR, Cahir-McFarland E (2011) IKKbeta and NF-kappaB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1. Cancer Res 71:7291\u20137300. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-1715","journal-title":"Cancer Res"},{"key":"2112_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/bjh.13065","volume":"167","author":"JS Blachly","year":"2014","unstructured":"Blachly JS, Baiocchi RA (2014) Targeting PI3-kinase (PI3K), AKT and mTOR axis in lymphoma. Br J Haematol 167:19\u201332. https:\/\/doi.org\/10.1111\/bjh.13065","journal-title":"Br J Haematol"},{"key":"2112_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","volume":"7","author":"RJ DeBerardinis","year":"2008","unstructured":"DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7:11\u201320. https:\/\/doi.org\/10.1016\/j.cmet.2007.10.002","journal-title":"Cell Metab"},{"key":"2112_CR23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/1097-0142(197808)42:2<693::AID-CNCR2820420241>3.0.CO;2-J","volume":"42","author":"KJ Lewin","year":"1978","unstructured":"Lewin KJ, Ranchod M, Dorfman RF (1978) Lymphomas of the Gastrointestinal tract: a study of 117 cases presenting with Gastrointestinal disease. Cancer 42:693\u2013707.","journal-title":"Cancer"},{"key":"2112_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40164-022-00325-7","volume":"11","author":"SS Li","year":"2022","unstructured":"Li SS, Zhai XH, Liu HL, Liu TZ, Cao TY, Chen DM, Xiao LX, Gan XQ, Cheng K, Hong WJ, Huang Y, Lian YF, Xiao J (2022) Whole-exome sequencing analysis identifies distinct mutational profile and novel prognostic biomarkers in primary Gastrointestinal diffuse large B-cell lymphoma. Exp Hematol Oncol 11:71. https:\/\/doi.org\/10.1186\/s40164-022-00325-7","journal-title":"Exp Hematol Oncol"},{"key":"2112_CR25","doi-asserted-by":"publisher","first-page":"1038570","DOI":"10.3389\/fimmu.2022.1038570","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y, Yang Y, Liu J, Zeng Y, Guo Q, Guo J, Guo L, Lu H, Liu W (2022) Establishment and validation of a carbohydrate metabolism-related gene signature for prognostic model and immune response in acute myeloid leukemia. Front Immunol 13:1038570. https:\/\/doi.org\/10.3389\/fimmu.2022.1038570","journal-title":"Front Immunol"},{"key":"2112_CR26","doi-asserted-by":"publisher","first-page":"1021678","DOI":"10.3389\/fimmu.2023.1021678","volume":"14","author":"J Li","year":"2023","unstructured":"Li J, Zhang S, Chen S, Yuan Y, Zuo M, Li T, Wang Z, Liu Y (2023) Lipid metabolism-related gene signature predicts prognosis and depicts tumor microenvironment immune landscape in gliomas. Front Immunol 14:1021678. https:\/\/doi.org\/10.3389\/fimmu.2023.1021678","journal-title":"Front Immunol"},{"key":"2112_CR27","doi-asserted-by":"publisher","first-page":"1018334","DOI":"10.3389\/fimmu.2022.1018334","volume":"13","author":"Y Xie","year":"2022","unstructured":"Xie Y, Chen H, Fang JY (2022) Amino acid metabolism-based molecular classification of colon adenocarcinomavia in Silico analysis. Front Immunol 13:1018334. https:\/\/doi.org\/10.3389\/fimmu.2022.1018334","journal-title":"Front Immunol"},{"key":"2112_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910301","author":"I Tsochantaridis","year":"2024","unstructured":"Tsochantaridis I, Brisimis D, Tsifintaris M, Anastasiadou A, Lazos E, Ermogenous A, Christou S, Antonopoulou N, Panayiotidis MI, Koukourakis MI, Giatromanolaki A, Pappa A (2024) Exploring the role and pathophysiological significance of aldehyde dehydrogenase 1B1 (ALDH1B1) in human lung adenocarcinoma. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms251910301","journal-title":"Int J Mol Sci"},{"key":"2112_CR29","doi-asserted-by":"publisher","first-page":"e0121648","DOI":"10.1371\/journal.pone.0121648","volume":"10","author":"S Singh","year":"2015","unstructured":"Singh S, Arcaroli J, Chen Y, Thompson DC, Messersmith W, Jimeno A, Vasiliou V (2015) ALDH1B1 is crucial for colon tumorigenesis by modulating Wnt\/beta-Catenin, Notch and PI3K\/Akt signaling pathways. PLoS ONE 10:e0121648. https:\/\/doi.org\/10.1371\/journal.pone.0121648","journal-title":"PLoS ONE"},{"key":"2112_CR30","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1182\/blood.2020010187","volume":"137","author":"A Iannello","year":"2021","unstructured":"Iannello A, Vitale N, Coma S, Arruga F, Chadburn A, Di Napoli A, Laudanna C, Allan JN, Furman RR, Pachter JA, Deaglio S, Vaisitti T (2021) Synergistic efficacy of the dual PI3K-delta\/gamma inhibitor Duvelisib with the Bcl-2 inhibitor venetoclax in Richter syndrome PDX models. Blood 137:3378\u20133389. https:\/\/doi.org\/10.1182\/blood.2020010187","journal-title":"Blood"},{"key":"2112_CR31","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1016\/j.drudis.2019.09.002","volume":"24","author":"AHC Vlot","year":"2019","unstructured":"Vlot AHC, Aniceto N, Menden MP, Ulrich-Merzenich G, Bender A (2019) Applying synergy metrics to combination screening data: agreements, disagreements and pitfalls. Drug Discov Today 24:2286\u20132298. https:\/\/doi.org\/10.1016\/j.drudis.2019.09.002","journal-title":"Drug Discov Today"},{"key":"2112_CR32","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1186\/s12967-023-04617-2","volume":"21","author":"SL Duan","year":"2023","unstructured":"Duan SL, Wu M, Zhang ZJ, Chang S (2023) The potential role of reprogrammed glucose metabolism: an emerging actionable codependent target in thyroid cancer. J Transl Med 21:735. https:\/\/doi.org\/10.1186\/s12967-023-04617-2","journal-title":"J Transl Med"},{"key":"2112_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/metabo12121214","volume":"26","author":"Y Nagayama","year":"2022","unstructured":"Nagayama Y, Hamada K (2022) Reprogramming of cellular metabolism and its therapeutic applications in thyroid cancer. Metabolites. https:\/\/doi.org\/10.3390\/metabo12121214","journal-title":"Metabolites"},{"key":"2112_CR34","doi-asserted-by":"publisher","first-page":"216285","DOI":"10.1016\/j.canlet.2023.216285","volume":"567","author":"M Chen","year":"2023","unstructured":"Chen M, Cen K, Song Y, Zhang X, Liou YC, Liu P, Huang J, Ruan J, He J, Ye W, Wang T, Huang X, Yang J, Jia Y, Liang X, Shen P, Wang Q, Liang T (2023) NUSAP1-LDHA-Glycolysis-Lactate feedforward loop promotes Warburg effect and metastasis in pancreatic ductal adenocarcinoma. Cancer Lett 567:216285. https:\/\/doi.org\/10.1016\/j.canlet.2023.216285","journal-title":"Cancer Lett"},{"key":"2112_CR35","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.167007","author":"Q Wang","year":"2023","unstructured":"Wang Q, Sun N, Meixner R, Le Gleut R, Kunzke T, Feuchtinger A, Wang J, Shen J, Kircher S, Dischinger U, Weigand I, Beuschlein F, Fassnacht M, Kroiss M, Walch A (2023) Metabolic heterogeneity in adrenocortical carcinoma impacts patient outcomes. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.167007","journal-title":"JCI Insight"},{"key":"2112_CR36","doi-asserted-by":"publisher","first-page":"611","DOI":"10.20517\/cdr.2023.60","volume":"6","author":"K Laubach","year":"2023","unstructured":"Laubach K, Turan T, Mathew R, Wilsbacher J, Engelhardt J, Samayoa J (2023) Tumor-intrinsic metabolic reprogramming and how it drives resistance to anti-PD-1\/PD-L1 treatment. Cancer Drug Resist 6:611\u2013641. https:\/\/doi.org\/10.20517\/cdr.2023.60","journal-title":"Cancer Drug Resist"},{"key":"2112_CR37","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0000000000000998","author":"JM Siqueira","year":"2023","unstructured":"Siqueira JM, Vega M, Pimentel GD (2023) Amino acids and cancer: potential for therapies? Curr Opin clin. Curr Opin Clin Nutr Metab Care https:\/\/doi.org\/10.1097\/MCO.0000000000000998. Nutr Metab Care","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2112_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/nu15214677","author":"I Castellano","year":"2023","unstructured":"Castellano I, Gallo F, Durelli P, Monge T, Fadda M, Metovic J, Cassoni P, Borella F, Raucci C, Menischetti M, Beano A, Migliaretti G, Finocchiaro C (2023) Impact of caloric restriction in breast cancer patients treated with neoadjuvant chemotherapy: A prospective case control study. https:\/\/doi.org\/10.3390\/nu15214677","journal-title":"Nutrients"},{"key":"2112_CR39","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s00520-023-08147-x","volume":"31","author":"Y Yu","year":"2023","unstructured":"Yu Y, Wu J, Wu H, Wang Z, Wu S, Hong L, Xu B, Shao L (2023) A large-scale study integrating nutritional indicators and clinicopathological parameters to evaluate prognosis, follow-up, and postoperative chemotherapy decisions in rectal cancer patients. Support Care Cancer 31:686. https:\/\/doi.org\/10.1007\/s00520-023-08147-x","journal-title":"Support Care Cancer"},{"key":"2112_CR40","doi-asserted-by":"publisher","first-page":"771","DOI":"10.21147\/j.issn.1000-9604.2019.05.07","volume":"31","author":"HC Huang","year":"2019","unstructured":"Huang HC, Wen XZ, Xue H, Chen RS, Ji JF, Xu L (2019) Phosphoglucose isomerase gene expression as a prognostic biomarker of gastric cancer. Chin J Cancer Res 31:771\u2013784. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2019.05.07","journal-title":"Chin J Cancer Res"},{"key":"2112_CR41","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2019.03.14","author":"F Luo","year":"2019","unstructured":"Luo F, Li Y, Yuan F, Zuo J (2019) Hexokinase II promotes the Warburg effect by phosphorylating alpha subunit of pyruvate dehydrogenase. Chin J Cancer Res. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2019.03.14. 31:521\u2013\u200932","journal-title":"Chin J Cancer Res"},{"key":"2112_CR42","doi-asserted-by":"publisher","first-page":"717182","DOI":"10.3389\/fcell.2021.717182","volume":"9","author":"J Xu","year":"2021","unstructured":"Xu J, Guo Y, Ning W, Wang X, Li S, Chen Y, Ma L, Qu Y, Song Y, Zhang H (2021) Comprehensive analyses of glucose metabolism in glioma reveal the glioma-Promoting effect of GALM. Front Cell Dev Biol 9:717182. https:\/\/doi.org\/10.3389\/fcell.2021.717182","journal-title":"Front Cell Dev Biol"},{"key":"2112_CR43","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/nm.4418","volume":"23","author":"WX Mai","year":"2017","unstructured":"Mai WX, Gosa L, Daniels VW, Ta L, Tsang JE, Higgins B, Gilmore WB, Bayley NA, Harati MD, Lee JT, Yong WH, Kornblum HI, Bensinger SJ, Mischel PS, Rao PN, Clark PM, Cloughesy TF, Letai A, Nathanson DA (2017) Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma. Nat Med 23:1342\u20131351. https:\/\/doi.org\/10.1038\/nm.4418","journal-title":"Nat Med"},{"key":"2112_CR44","doi-asserted-by":"publisher","first-page":"1245629","DOI":"10.3389\/fendo.2023.1245629","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Liu N, Zhou X, Zhao L, Wei W, Hu J, Luo Z (2023) Constructing a prognostic model for head and neck squamous cell carcinoma based on glucose metabolism related genes. Front Endocrinol (Lausanne) 14:1245629. https:\/\/doi.org\/10.3389\/fendo.2023.1245629","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2112_CR45","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12935-023-03014-5","volume":"23","author":"X Miao","year":"2023","unstructured":"Miao X, Wang H, Fan C, Song Q, Ding R, Wu J, Hu H, Chen K, Ji P, Wen Q, Shi M, Ye B, Fu D, Xiang M (2023) Enhancing prognostic accuracy in head and neck squamous cell carcinoma chemotherapy via a lipid metabolism-related clustered polygenic model. Cancer Cell Int 23:164. https:\/\/doi.org\/10.1186\/s12935-023-03014-5","journal-title":"Cancer Cell Int"},{"key":"2112_CR46","doi-asserted-by":"publisher","first-page":"1056648","DOI":"10.3389\/fnut.2022.1056648","volume":"9","author":"H Zhou","year":"2022","unstructured":"Zhou H, Wang F, Niu T (2022) Prediction of prognosis and immunotherapy response of amino acid metabolism genes in acute myeloid leukemia. Front Nutr 9:1056648. https:\/\/doi.org\/10.3389\/fnut.2022.1056648","journal-title":"Front Nutr"},{"key":"2112_CR47","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41571-019-0203-7","volume":"16","author":"X Li","year":"2019","unstructured":"Li X, Wenes M, Romero P, Huang SC, Fendt SM, Ho PC (2019) Navigating metabolic pathways to enhance antitumour immunity and immunotherapy. Nat Rev Clin Oncol 16:425\u2013441. https:\/\/doi.org\/10.1038\/s41571-019-0203-7","journal-title":"Nat Rev Clin Oncol"},{"key":"2112_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0273-y","author":"RD Leone","year":"2020","unstructured":"Leone RD, Powell JD (2020) Metabolism of immune cells in cancer. Nat Rev Cancer. https:\/\/doi.org\/10.1038\/s41568-020-0273-y.","journal-title":"Nat Rev Cancer"},{"key":"2112_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/cells12121615","author":"S Sindhu","year":"2023","unstructured":"Sindhu S, Ahmad R (2023) Metabolic inflammation and cellular immunity. Cells https:\/\/doi.org\/10.3390\/cells12121615. Cells 12","journal-title":"Cells"},{"issue":"5","key":"2112_CR50","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/(SICI)1097-0215(19960529)66:5<686::AID-IJC17>3.0.CO;2-2","volume":"66","author":"RE Toes","year":"1996","unstructured":"Toes RE, Kast WM, Blom RJ, Bakker SC, Offringa R, Melief CJ (1996) Efficient tumor eradication by adoptively transferred cytotoxic T-cell clones in allogeneic hosts. Int J Cancer 66(5):686\u2013691.","journal-title":"Int J Cancer"},{"key":"2112_CR51","doi-asserted-by":"publisher","first-page":"6375","DOI":"10.1158\/0008-5472.CAN-17-0381","volume":"77","author":"W He","year":"2017","unstructured":"He W, Zhang H, Han F, Chen X, Lin R, Wang W, Qiu H, Zhuang Z, Liao Q, Zhang W, Cai Q, Cui Y, Jiang W, Wang H, Ke Z (2017) CD155T\/TIGIT signaling regulates CD8(+) T-cell metabolism and promotes tumor progression in human gastric cancer. Cancer Res 77:6375\u20136388. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0381","journal-title":"Cancer Res"},{"key":"2112_CR52","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.molcel.2020.10.015","volume":"80","author":"JK Byun","year":"2020","unstructured":"Byun JK, Park M, Lee S, Yun JW, Lee J, Kim JS, Cho SJ, Jeon HJ, Lee IK, Choi YK, Park KG (2020) Inhibition of glutamine utilization synergizes with immune checkpoint inhibitor to promote antitumor immunity. Mol Cell 80:592\u2013606e8. https:\/\/doi.org\/10.1016\/j.molcel.2020.10.015","journal-title":"Mol Cell"},{"key":"2112_CR53","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1158\/1541-7786.MCR-19-0517","volume":"18","author":"G Ma","year":"2020","unstructured":"Ma G, Liang Y, Chen Y, Wang L, Li D, Liang Z, Wang X, Tian D, Yang X, Niu H (2020) Glutamine deprivation induces PD-L1 expression via activation of EGFR\/ERK\/c-Jun signaling in renal cancer. Mol Cancer Res 18:324\u2013339. https:\/\/doi.org\/10.1158\/1541-7786.MCR-19-0517","journal-title":"Mol Cancer Res"},{"key":"2112_CR54","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1172\/JCI31911","volume":"117","author":"MD Sharma","year":"2007","unstructured":"Sharma MD, Baban B, Chandler P, Hou DY, Singh N, Yagita H, Azuma M, Blazar BR, Mellor AL, Munn DH (2007) Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J Clin Invest 117:2570\u20132582. https:\/\/doi.org\/10.1172\/JCI31911","journal-title":"J Clin Invest"},{"key":"2112_CR55","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/08830185.2012.679989","volume":"31","author":"B Yang","year":"2012","unstructured":"Yang B, Wang X, Ren X (2012) Amino acid metabolism related to immune tolerance by MDSCs. Int Rev Immunol 31:177\u2013183. https:\/\/doi.org\/10.3109\/08830185.2012.679989","journal-title":"Int Rev Immunol"},{"key":"2112_CR56","doi-asserted-by":"publisher","first-page":"902143","DOI":"10.3389\/fimmu.2022.902143","volume":"13","author":"F Jiang","year":"2022","unstructured":"Jiang F, Luo F, Zeng N, Mao Y, Tang X, Wang J, Hu Y, Wu C (2022) Characterization of fatty acid Metabolism-Related genes landscape for predicting prognosis and aiding immunotherapy in glioma patients. Front Immunol 13:902143. https:\/\/doi.org\/10.3389\/fimmu.2022.902143","journal-title":"Front Immunol"},{"key":"2112_CR57","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.critrevonc.2007.01.003","volume":"63","author":"AJ Ferreri","year":"2007","unstructured":"Ferreri AJ, Montalban C (2007) Primary diffuse large B-cell lymphoma of the stomach. Crit Rev Oncol Hematol 63:65\u201371. https:\/\/doi.org\/10.1016\/j.critrevonc.2007.01.003","journal-title":"Crit Rev Oncol Hematol"},{"key":"2112_CR58","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1136\/gut.52.6.912","volume":"52","author":"A Ruskone-Fourmestraux","year":"2003","unstructured":"Ruskone-Fourmestraux A, Dragosics B, Morgner A, Wotherspoon A, De Jong D (2003) Paris staging system for primary Gastrointestinal lymphomas. Gut 52:912\u2013913. https:\/\/doi.org\/10.1136\/gut.52.6.912","journal-title":"Gut"},{"key":"2112_CR59","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.cbi.2012.10.026","volume":"202","author":"V Vasiliou","year":"2013","unstructured":"Vasiliou V, Thompson DC, Smith C, Fujita M, Chen Y (2013) Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells. Chem Biol Interact 202:2\u201310. https:\/\/doi.org\/10.1016\/j.cbi.2012.10.026","journal-title":"Chem Biol Interact"},{"key":"2112_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2011.11.033","author":"G Muzio","year":"2012","unstructured":"Muzio G, Maggiora M, Paiuzzi E, Oraldi M, Canuto RA (2012) Aldehyde dehydrogenases and cell proliferation. Free Radic Biol Med. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.11.033. 52:735\u2013\u200946","journal-title":"Free Radic Biol Med"},{"key":"2112_CR61","doi-asserted-by":"publisher","first-page":"394632023120696","DOI":"10.1177\/03946320231206966","volume":"37","author":"Y Kuang","year":"2023","unstructured":"Kuang Y, Feng J, Jiang Y, Jin Q, Wang Q, Zhang C, He Y (2023) Prognostic and immunological role of acetaldehyde dehydrogenase 1B1 in human tumors: A pan-cancer analysis. Int J Immunopathol Pharmacol 37:3946320231206966. https:\/\/doi.org\/10.1177\/03946320231206966","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2112_CR62","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.bbrc.2015.06.011","volume":"463","author":"S Singh","year":"2015","unstructured":"Singh S, Chen Y, Matsumoto A, Orlicky DJ, Dong H, Thompson DC, Vasiliou V (2015) ALDH1B1 links alcohol consumption and diabetes. Biochem Biophys Res Commun 463:768\u2013773. https:\/\/doi.org\/10.1016\/j.bbrc.2015.06.011","journal-title":"Biochem Biophys Res Commun"},{"key":"2112_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9010044","author":"I Tsochantaridis","year":"2021","unstructured":"Tsochantaridis I, Roupas A, Voulgaridou GP, Giatromanolaki A, Koukourakis MI, Panayiotidis MI, Pappa A (2021) Aldehyde dehydrogenase 1B1 is associated with altered cell morphology, proliferation, migration and chemosensitivity in human colorectal adenocarcinoma cells. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines9010044","journal-title":"Biomedicines"},{"key":"2112_CR64","doi-asserted-by":"publisher","first-page":"20679","DOI":"10.1073\/pnas.1901075116","volume":"116","author":"E Mameishvili","year":"2019","unstructured":"Mameishvili E, Serafimidis I, Iwaszkiewicz S, Lesche M, Reinhardt S, Bolicke N, Buttner M, Stellas D, Papadimitropoulou A, Szabolcs M, Anastassiadis K, Dahl A, Theis F, Efstratiadis A, Gavalas A (2019) Aldh1b1 expression defines progenitor cells in the adult pancreas and is required for Kras-induced pancreatic cancer. Proc Natl Acad Sci U S A 116:20679\u201320688. https:\/\/doi.org\/10.1073\/pnas.1901075116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2112_CR65","doi-asserted-by":"publisher","first-page":"118544","DOI":"10.1016\/j.lfs.2020.118544","volume":"262","author":"X Wang","year":"2020","unstructured":"Wang X, Li C, Yao W, Tian Z, Liu Z, Ge H (2020) MicroRNA-761 suppresses tumor progression in osteosarcoma via negatively regulating ALDH1B1. Life Sci 262:118544. https:\/\/doi.org\/10.1016\/j.lfs.2020.118544","journal-title":"Life Sci"},{"key":"2112_CR66","doi-asserted-by":"publisher","first-page":"183","DOI":"10.14670\/HH-18-304","volume":"36","author":"H Wang","year":"2021","unstructured":"Wang H, Li Y, Zhou D, Li X, Jia S, Qi S, Huang J (2021) Aldehyde dehydrogenase 1B1 is a potential marker of colorectal tumors. Histol Histopathol 36:183\u2013194. https:\/\/doi.org\/10.14670\/HH-18-304","journal-title":"Histol Histopathol"},{"key":"2112_CR67","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41589-022-01048-w","volume":"18","author":"Z Feng","year":"2022","unstructured":"Feng Z, Hom ME, Bearrood TE, Rosenthal ZC, Fernandez D, Ondrus AE, Gu Y, McCormick AK, Tomaske MG, Marshall CR, Kline T, Chen CH, Mochly-Rosen D, Kuo CJ, Chen JK (2022) Targeting colorectal cancer with small-molecule inhibitors of ALDH1B1. Nat Chem Biol 18:1065\u20131075. https:\/\/doi.org\/10.1038\/s41589-022-01048-w","journal-title":"Nat Chem Biol"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-025-02112-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-025-02112-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-025-02112-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T05:30:55Z","timestamp":1749879055000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-025-02112-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":67,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2112"],"URL":"https:\/\/doi.org\/10.1007\/s10495-025-02112-1","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"28 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. The study was approved by the Research Ethics Committee in Shandong Provincial Hospital. Informed consent was waived because of its retrospective nature.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"Statement","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}